Showing results (101-110 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|March 4, 2025
Sampling from covariate distribution may not always be necessary in PK/PD simulations: illustrative examples with antibioticsFeiyan Liu, Zeneng Cheng, Sanwang Li, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 17, 2025
Defining preclinical efficacy with the DNAPK inhibitor AZD7648 in combination with olaparib: a minimal systems pharmacokinetic-pharmacodynamic modelJoost DeJongh, Elaine Cadogan, Michael Davies, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 29, 2006
Structural identifiability of physiologically based pharmacokinetic modelsJames W T YatesJournal of Pharmacokinetics and Pharmacodynamics|July 15, 2006
Determination of drug binding to plasma proteins using competitive equilibrium binding to dextran-coated charcoalLeonid M BerezhkovskiyJournal of Pharmacokinetics and Pharmacodynamics|January 9, 2007
Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model applicationMicha Levi, Delia A Dempsey, Neal L Benowitz, et al.Journal of Pharmacokinetics and Pharmacodynamics|December 1, 2006
Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorderAn Vermeulen, Vladimir Piotrovsky, Elizabeth A LudwigJournal of Pharmacokinetics and Pharmacodynamics|October 21, 2006
A pharmacokinetic formalism explicitly integrating the patient drug complianceJun Li, Fahima NekkaJournal of Pharmacokinetics and Pharmacodynamics|January 8, 2023
Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modelingMutaz M Jaber, Richard C BrundageJournal of Pharmacokinetics and Pharmacodynamics|January 21, 2019
Population pharmacokinetic analysis of danvatirsen supporting flat dosing switchHongmei Xu, Xiao Tong, Ganesh Mugundu, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 3, 2021
A quantitative systems pharmacological approach identified activation of JNK signaling pathway as a promising treatment strategy for refractory HER2 positive breast cancerYesenia L Franco, Vidya Ramakrishnan, Tanaya R Vaidya, et al.Pageof 107